Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Vesico-Ureteral Reflux

ClinicalTrials.gov lists 29 trials for Vesico-Ureteral Reflux or a narrower condition beneath it.

MeSH D014718 Urogenital Diseases C12
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 1 Phase 3 Phase 3 6 Phase 4 Phase 4 3 Not applicable Not applicable 12 Observational Observational 5 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 1 Phase 3 Phase 3 6 Phase 4 Phase 4 3 Not applicable Not applicable 12 Observational Observational 5

Trials per phase

29 of the 29 trials are tagged with Vesico-Ureteral Reflux itself; the rest are tagged with a narrower condition beneath it.

Get the Vesico-Ureteral Reflux report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Vesico-Ureteral Reflux trials start? (20)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 1/2
  • Phase 2
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 3

1999: 2 trials (Phase 4 1, Phase 3 1) 2000: 1 trials (Phase 4 1) 2004: 1 trials (Not applicable 1) 2005: 1 trials (Observational 1) 2006: 1 trials (Not applicable 1) 2007: 2 trials (Phase 3 2) 2008: 1 trials (Not applicable 1) 2009: 2 trials (Not applicable 1, Phase 3 1) 2010: 2 trials (Observational 2) 2011: 2 trials (Not applicable 2) 2013: 2 trials (Observational 1, Phase 3 1) 2014: 3 trials (Observational 1, Phase 4 1, Phase 1/2 1) 2015: 1 trials (Not applicable 1) 2016: 1 trials (Phase 2 1) 2017: 1 trials (Not applicable 1) 2020: 1 trials (Not applicable 1) 2021: 1 trials (Not applicable 1) 2022: 1 trials (Not applicable 1) 2024: 1 trials (Phase 3 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2024 1
2022 1
2021 1
2020 1
2017 1
2016 1
2015 1
2014 3
2013 2

No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Vesico-Ureteral Reflux trials in? (7)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 1
Phase 2 1
Phase 3 6
Phase 4 3
Not applicable 12
Observational 5

How many Vesico-Ureteral Reflux trials are recruiting? (6)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 2
Recruiting 2
Completed 13
Terminated 2
Withdrawn 4

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Vesico-Ureteral Reflux trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
FDA Office of Orphan Products Development 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1

Interventions as named in the registry (15)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Sulfamethoxazole trimethoprim 3
Definity Contrast 1
antibiotic to reduce the recurrence of infection 1
D. Midazolam 1
chondrocyte-alginate gel suspension 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Vesico-Ureteral Reflux? (103)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages